Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
11126
|
Gene name
Gene Name - the full gene name approved by the HGNC.
|
CD160 molecule |
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
CD160 |
Synonyms (NCBI Gene)
Gene synonyms aliases
|
BY55, NK1, NK28 |
Chromosome
Chromosome number
|
1 |
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
1q21.1 |
Summary
Summary of gene provided in NCBI Entrez Gene.
|
CD160 is an 27 kDa glycoprotein which was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predic |
UniProt ID |
O95971
|
Protein name |
CD160 antigen (Natural killer cell receptor BY55) (CD antigen CD160) [Cleaved into: CD160 antigen, soluble form] |
Protein function |
[CD160 antigen]: Receptor on immune cells capable to deliver stimulatory or inhibitory signals that regulate cell activation and differentiation. Exists as a GPI-anchored and as a transmembrane form, each likely initiating distinct signaling pat |
PDB |
6NG3
,
6NG9
,
6NGG
,
7MSG
|
Family and domains |
|
Tissue specificity |
TISSUE SPECIFICITY: Expression is restricted to functional NK and cytotoxic T lymphocytes. Expressed in viral-specific effector memory and terminally differentiated effector memory CD8+ T cells. Expressed in memory and activated CD4+ T cell subsets (at pr |
Sequence |
MLLEPGRGCCALAILLAIVDIQSGGCINITSSASQEGTRLNLICTVWHKKEEAEGFVVFL CKDRSGDCSPETSLKQLRLKRDPGIDGVGEISSQLMFTISQVTPLHSGTYQCCARSQKSG IRLQGHFFSILFTETGNYTVTGLKQRQHLEFSHNEGTLSSGFLQEKVWVMLVTSLVALQA L
|
|
Sequence length |
181 |
Interactions |
View interactions
|
Causal |
Disease term |
Disease name |
dbSNP ID |
References |
Breast carcinoma |
Breast Carcinoma |
rs80359671, rs11540652, rs28934575, rs28897672, rs137886232, rs193922376, rs80357783, rs80359306, rs80359405, rs80359507, rs80359598, rs80358429, rs397507683, rs397515636, rs80359451, rs397507859, rs80359709, rs80359742, rs80359205, rs80357627, rs80357004, rs80357571, rs80357767, rs80357653, rs80358086, rs80357608, rs28897696, rs41293465, rs146650273, rs63751017, rs63750617, rs63750726, rs63750199, rs63749848, rs398122618, rs398122653, rs397509211, rs80357791, rs121912666, rs587778541, rs121908698, rs536907995, rs587781302, rs140342925, rs587781506, rs587782652, rs587782849, rs587783057, rs139770721, rs374950566, rs786202800, rs863224451, rs377153250, rs747727055, rs876658804, rs780001540, rs760815829, rs878854926, rs775248597, rs886040658, rs886040192, rs786203523, rs886040319, rs397508006, rs587782011, rs1060502772, rs1555461727, rs1553333072, rs1114167702, rs1257401983, rs886040950, rs1060502759, rs774684620, rs142947311, rs1555580883, rs748513310, rs376170600, rs863224499, rs1593909229, rs748453607, rs1294578913, rs1574737047, rs1593909960, rs2081922847, rs2082559544, rs2053694038 View all (71 more) |
29059683 |
|
Unknown |
Disease term |
Disease name |
Evidence |
References |
Source |
Gout |
Gout |
|
|
GWAS |
Breast Cancer |
Breast Cancer |
Importantly, breast cancer patients bearing PRC2 LOF mutations displayed significantly worse prognosis compared with PRC2 wild-type patients |
|
GWAS, CBGDA |
|
Associations from Text Mining |
Disease Name |
Relationship Type |
References |
Abortion Spontaneous |
Associate
|
28404628 |
Adenocarcinoma of Lung |
Associate
|
35946526, 37014183 |
Arthritis Rheumatoid |
Associate
|
22449398 |
Atherosclerosis |
Associate
|
26071079 |
Autoimmune Diseases |
Associate
|
30842773, 34238277 |
Breast Neoplasms |
Associate
|
37996402 |
Colitis Ulcerative |
Associate
|
31191543 |
Colorectal Neoplasms |
Stimulate
|
32393998 |
COVID 19 |
Associate
|
38538269 |
Crohn Disease |
Associate
|
31191543 |
Depressive Disorder |
Associate
|
23064081 |
Down Syndrome |
Associate
|
35222360 |
Drug Related Side Effects and Adverse Reactions |
Stimulate
|
35470232 |
Esophageal Neoplasms |
Associate
|
27577071 |
Gastrointestinal Neoplasms |
Associate
|
33788641 |
Graves Disease |
Associate
|
30842773, 34238277 |
HIV Infections |
Associate
|
28335609 |
HIV Infections |
Inhibit
|
36110864 |
Leukemia Hairy Cell |
Stimulate
|
21715317 |
Leukemia Lymphocytic Chronic B Cell |
Stimulate
|
21715317 |
Leukemia Lymphocytic Chronic B Cell |
Associate
|
23247726, 24246502, 33931471 |
Leukemia Myeloid Acute |
Inhibit
|
33239726 |
Lung Neoplasms |
Associate
|
37014183 |
Lymphoma B Cell |
Associate
|
21715317 |
Lymphoma Mantle Cell |
Associate
|
21715317 |
Melanoma |
Associate
|
35428910 |
Mood Disorders |
Associate
|
23064081 |
Mycosis Fungoides |
Associate
|
25044837 |
Nasopharyngeal Carcinoma |
Associate
|
36438903 |
Neoplasm Residual |
Associate
|
21715317 |
Neoplasms |
Associate
|
21715317, 32393998, 34858395, 35428910, 35470232, 37014183 |
Neoplasms |
Stimulate
|
37014183 |
Neurologic Manifestations |
Associate
|
23064081 |
Pancreatic Neoplasms |
Associate
|
32055919 |
Prostatic Neoplasms |
Associate
|
36124532 |
Sleep Deprivation |
Associate
|
38538269 |
Stomach Neoplasms |
Associate
|
39244216 |
Thyroiditis Autoimmune |
Associate
|
34238277 |
Urinary Bladder Neoplasms |
Associate
|
34858395 |
|